Artelo Biosciences, Inc. (ARTL) Press Releases https://ir.artelobio.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/artelobio/files/theme/images/logo-sm.png Artelo Biosciences, Inc. Logo Equisolve Investor Relations Suite <![CDATA[Artelo Biosciences Announces Strategic Collaboration with Artificial Intelligence (AI) Leader ScienceMachine Highlighting New Expansion Opportunities and Insights for FABP5 Inhibitor Development]]> https://ir.artelobio.com/news-events/press-releases/detail/186/artelo-biosciences-announces-strategic-collaboration-with Tue, 28 Apr 26 08:25:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/186/artelo-biosciences-announces-strategic-collaboration-with <![CDATA[Artelo Announces Peer-Reviewed Publication Supporting its FABP5 Inhibitor ART26.12 as a Novel Pain Treatment with a Potentially First-in-Class Profile]]> https://ir.artelobio.com/news-events/press-releases/detail/185/artelo-announces-peer-reviewed-publication-supporting-its Mon, 20 Apr 26 07:50:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/185/artelo-announces-peer-reviewed-publication-supporting-its <![CDATA[Artelo Biosciences Regains Compliance with Nasdaq Listing Requirements]]> https://ir.artelobio.com/news-events/press-releases/detail/184/artelo-biosciences-regains-compliance-with-nasdaq-listing Tue, 07 Apr 26 07:50:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/184/artelo-biosciences-regains-compliance-with-nasdaq-listing <![CDATA[Artelo Biosciences Announces Closing of $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules]]> https://ir.artelobio.com/news-events/press-releases/detail/183/artelo-biosciences-announces-closing-of-11-0-million Mon, 30 Mar 26 16:46:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/183/artelo-biosciences-announces-closing-of-11-0-million <![CDATA[Artelo Biosciences Announces $11.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules]]> https://ir.artelobio.com/news-events/press-releases/detail/182/artelo-biosciences-announces-11-0-million-private Fri, 27 Mar 26 10:40:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/182/artelo-biosciences-announces-11-0-million-private <![CDATA[Artelo Biosciences Expands ART27.13 Development as a Potential Companion Therapy to GLP-1 Treatments]]> https://ir.artelobio.com/news-events/press-releases/detail/181/artelo-biosciences-expands-art27-13-development-as-a Wed, 25 Mar 26 16:05:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/181/artelo-biosciences-expands-art27-13-development-as-a <![CDATA[Artelo Announces Third-Party Fully Funded Clinical Study Agreement to Evaluate ART27.13 in Glaucoma Patients]]> https://ir.artelobio.com/news-events/press-releases/detail/178/artelo-announces-third-party-fully-funded-clinical-study Wed, 18 Mar 26 07:41:00 -0400 https://ir.artelobio.com/news-events/press-releases/detail/178/artelo-announces-third-party-fully-funded-clinical-study <![CDATA[Artelo Biosciences Announces Reverse Stock Split]]> https://ir.artelobio.com/news-events/press-releases/detail/177/artelo-biosciences-announces-reverse-stock-split Fri, 06 Mar 26 08:00:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/177/artelo-biosciences-announces-reverse-stock-split <![CDATA[Artelo Biosciences Provides Business Update Highlighting Clinical Progress and Reports Fiscal 2025 Year-End Financial Results]]> https://ir.artelobio.com/news-events/press-releases/detail/176/artelo-biosciences-provides-business-update-highlighting Tue, 24 Feb 26 08:00:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/176/artelo-biosciences-provides-business-update-highlighting <![CDATA[Artelo Bioscience Commends Presidential Executive Order Expanding CBD Research and Access; Highlights ART12.11 as a Leading Pharmaceutical-Grade Cannabidiol Candidate]]> https://ir.artelobio.com/news-events/press-releases/detail/175/artelo-bioscience-commends-presidential-executive-order Tue, 23 Dec 25 09:00:00 -0500 https://ir.artelobio.com/news-events/press-releases/detail/175/artelo-bioscience-commends-presidential-executive-order